Parameters | Subacute phase | Subchronic phase | ||||
---|---|---|---|---|---|---|
Treatment group | Control | P value | Treatment group | Control | p value | |
Number of animals analyzed | 11 | 12 | 12 | 12 | ||
WBCs (× 103/μl) | 11.17 ± 3.46 | 11.07 ± 1.79 | 0.93 | 8.26 ± 1.26 | 8.26 ± 1.26 | 0.51 |
RBCs (× 106/μl) | 5.91 ± 0.71 | 6.33 ± 0.69 | 0.17 | 6.42 ± .40 | 6.42 ± 0.40 | 0.22 |
HGB (g/dl) | 11.08 ± 0.95 | 11.60 ± 1.07 | 0.23 | 12.31 ± .84 | 12.31 ± 0.84 | 1.0 |
HCT (%) | 31.10 ± 3.05 | 31.46 ± 3.50 | 0.79 | 32.67 ± 2.03 | 32.67 ± 2.03 | 0.97 |
MCV (fl) | 50.51 ± 1.91 | 50.20 ± 2.51 | 0.74 | 49.74 ± 1.14 | 49.74 ± 1.14 | 0.86 |
MCH (pg) | 18.79 ± 1.54 | 17.60 ± 1.49 | 0.07 | 19.61 ± .85 | 19.61 ± .85 | 1.0 |
MCHC (g/dl) | 36.64 ± 0.97 | 36.42 ± 0.97 | 0.59 | 38.90 ± 1.23 | 38.90 ± 1.23 | 0.90 |
PLT (103/μl) | 485.74 ± 60.97 | 505.42 ± 45.0 | 0.38 | 542.08 ± 70.93 | 542.08 ± 70.93 | 0.59 |
RDW (%) | 12.51 ± 1.24 | 12.35 ± 1.17 | 0.75 | 11.31 ± .53 | 11.31 ± 0.53 | 0.67 |
Reticulocytes (%) | 1.86 ± 0.28 | 1.85 ± 0.21 | 0.25 | 1.08 ± 0.16 | 1.08 ± 0.16 | 0.91 |